Michael L. Scanlon

TL;DR: Informing children of their own HIV status is an important aspect of long‐term disease management, yet there is little evidence of how and when this type of disclosure takes place in resource‐limited settings and its impact.

TL;DR: There is little evidence for improving access and adherence among vulnerable groups such as women, children and adolescents, and other high-risk populations and for addressing major barriers, and recommendations for further research include health information technology, social-level factors like HIV stigma, and new research directions in cost-effectiveness, operations, and implementation.

TL;DR: The prevalence of disclosure and associated factors among a cohort of HIV-infected children and adolescents in Kenya and the likelihood of disclosure is associated with clinical and psychosocial factors are described.

TL;DR: Vreeman et al. as discussed by the authors evaluated ART adherence among HIV-infected children aged ≤ 14 years attending a large outpatient HIV clinic in Kenya and found that adherence varied significantly by adherence measure, suggesting that additional validation of adherence measures is needed.

TL;DR: As highly active antiretroviral therapy (HAART) transforms human immunodeficiency virus (HIV) into a manageable chronic disease, new challenges are emerging in treating children born with HIV, including a number of risks to their physical and psychological health due to HIV infection and its lifelong treatment.